Human Performance Engineering

Ph.D. students are challenged to discover new ideas, invent new products or break through barriers on existing problems. As a Ph.D. student I am leading a new area of research in the STEM discipline. As an industrial engineer, I am attempting to extend the reach of engineering methods and tools traditionally applied in manufacturing and service-related settings to the area of human performance. Human Performance Engineering, IE 402 008, is a new creative inquiry class that Dr. Kevin Taaffe and I have created. The research includes many focus areas such as quality, decision making, perception, game theory, biology, simulation, and disciplines from engineering to psychology to management and the sciences can all potentially play a role. For the last two semesters I have guided undergraduate students in investigating the cause and effect relationships in human performance in individual or team sports. As a research group, we are challenged to learn materials that are beyond our current knowledge base and to examine psychological and biological factors that affect decisions people make in a competitive environment. Moreover, we aim to quantify the extent to which changes to our mental and physical abilities translate into an increased performance during the sporting event

The Magnetic Electron Ion Spectrometer (MagEIS) Instruments Aboard the Radiation Belt Storm Probes (RBSP) Spacecraft

This paper describes the Magnetic Electron Ion Spectrometer (MagEIS) instruments aboard the RBSP spacecraft from an instrumentation and engineering point of view. There are four magnetic spectrometers aboard each of the two spacecraft, one low-energy unit (20–240 keV), two medium-energy units (80–1200 keV), and a high-energy unit (800–4800 keV). The high unit also contains a proton telescope (55 keV–20 MeV). The magnetic spectrometers focus electrons within a selected energy pass band upon a focal plane of several silicon detectors where pulse-height analysis is used to determine if the energy of the incident electron is appropriate for the electron momentum selected by the magnet. Thus each event is a two-parameter analysis, an approach leading to a greatly reduced background. The physics of these instruments are described in detail followed by the engineering implementation. The data outputs are described, and examples of the calibration results and early flight data presented

Rate constants for the reactions of O+ with N2 and O2 as a function of temperature (300–1800 K)

This is the publisher's version, also available electronically from http://scitation.aip.org/content/aip/journal/jcp/106/9/10.1063/1.473450.We have studied the rate constants for the reaction of O+ with N2 over the temperature range 300–1600 K and the reaction of O+ with O2 over the range 300 to 1800 K. The results are in good agreement with previous measurements made up to 900 K. The rate constant for the O+reaction with N2 shows a minimum in the temperature range 1100–1300 K. The increase above this temperature is due to N2 v=2 becoming populated. The rate constant for O++O2 shows a minimum in the 800–1100 K range. Comparing to previous drift tube measurements allows the rate constant for O2 (v>0) to be derived. The v>0 rate constant is approximately five times larger than the v=0 rate constant

Deformations of the Boson sp(4,R)sp(4,R) Representation and its Subalgebras

The boson representation of the sp(4,R) algebra and two distinct deformations of it, are considered, as well as the compact and noncompact subalgebras of each. The initial as well as the deformed representations act in the same Fock space. One of the deformed representation is based on the standard q-deformation of the boson creation and annihilation operators. The subalgebras of sp(4,R) (compact u(2) and three representations of the noncompact u(1,1) are also deformed and are contained in this deformed algebra. They are reducible in the action spaces of sp(4,R) and decompose into irreducible representations. The other deformed representation, is realized by means of a transformation of the q-deformed bosons into q-tensors (spinor-like) with respect to the standard deformed su(2). All of its generators are deformed and have expressions in terms of tensor products of spinor-like operators. In this case, an other deformation of su(2) appears in a natural way as a subalgebra and can be interpreted as a deformation of the angular momentum algebra so(3). Its representation is reducible and decomposes into irreducible ones that yields a complete description of the same

Generative technologies for model animation in the TopCased platform

International audienceDomain Specific Modeling Languages (DSML) are more and more used to handle high level concepts, and thus bring complex software development under control. The increasingly recurring definition of new languages raises the problem of the definition of support tools such as editor, simulator, compiler, etc. In this paper we propose generative technologies that have been designed to ease the development of model animation tools inside the TopCased platform. These tools rely on the automatically generated graphical editors of TopCased and provide additional generators for building model animator graphical interface. We also rely on an architecture for executable metamodel (i.e., the TopCased model execution metamodeling pattern) to bind the behavioral semantics of the modeling language. These tools were designed in a pragmatic manner by abstracting the various model animators that had been hand-coded in the TopCased project, and then validated by refactoring these animators

Characterization of Changes in Serum Anti-Glycan Antibodies in Crohn's Disease – a Longitudinal Analysis

INTRODUCTION: Anti-glycan antibodies are a promising tool for differential diagnosis and disease stratification of patients with Crohn's disease (CD). We longitudinally assessed level and status changes of anti-glycan antibodies over time in individual CD patients as well as determinants of this phenomenon. METHODS: 859 serum samples derived from a cohort of 253 inflammatory bowel disease (IBD) patients (207 CD, 46 ulcerative colitis (UC)) were tested for the presence of anti-laminarin (Anti-L), anti-chitin (Anti-C), anti-chitobioside (ACCA), anti-laminaribioside (ALCA), anti-mannobioside (AMCA) and anti-Saccharomyces cerevisiae (gASCA) antibodies by ELISA. All patients had at least two and up to eleven serum samples taken during the disease course. RESULTS: Median follow-up time for CD was 17.4 months (Interquartile range (IQR) 8.0, 31.6 months) and for UC 10.9 months (IQR 4.9, 21.0 months). In a subgroup of CD subjects marked changes in the overall immune response (quartile sum score) and levels of individual markers were observed over time. The marker status (positive versus negative) remained widely stable. Neither clinical phenotype nor NOD2 genotype was associated with the observed fluctuations. In a longitudinal analysis neither changes in disease activity nor CD behavior led to alterations in the levels of the glycan markers. The ability of the panel to discriminate CD from UC or its association with CD phenotypes remained stable during follow-up. In the serum of UC patients neither significant level nor status changes were observed. CONCLUSIONS: While the levels of anti-glycan antibodies fluctuate in a subgroup of CD patients the antibody status is widely stable over time

The aberrant asynchronous replication — characterizing lymphocytes of cancer patients — is erased following stem cell transplantation

<p>Abstract</p> <p>Background</p> <p>Aberrations of allelic replication timing are epigenetic markers observed in peripheral blood cells of cancer patients. The aberrant markers are non-cancer-type-specific and are accompanied by increased levels of sporadic aneuploidy. The study aimed at following the epigenetic markers and aneuploidy levels in cells of patients with haematological malignancies from diagnosis to full remission, as achieved by allogeneic stem cell transplantation (alloSCT).</p> <p>Methods</p> <p><it>TP53 </it>(a tumor suppressor gene assigned to chromosome 17), <it>AML1 </it>(a gene assigned to chromosome 21 and involved in the leukaemia-abundant 8;21 translocation) and the pericentomeric satellite sequence of chromosome 17 (<it>CEN17</it>) were used for replication timing assessments. Aneuploidy was monitored by enumerating the copy numbers of chromosomes 17 and 21. Replication timing and aneuploidy were detected cytogenetically using fluorescence <it>in situ </it>hybridization (FISH) technology applied to phytohemagglutinin (PHA)-stimulated lymphocytes.</p> <p>Results</p> <p>We show that aberrant epigenetic markers are detected in patients with hematological malignancies from the time of diagnosis through to when they are scheduled to undergo alloSCT. These aberrations are unaffected by the clinical status of the disease and are displayed both during accelerated stages as well as in remission. Yet, these markers are eradicated completely following stem cell transplantation. In contrast, the increased levels of aneuploidy (irreversible genetic alterations) displayed in blood lymphocytes at various stages of disease are not eliminated following transplantation. However, they do not elevate and remain unchanged (stable state). A demethylating anti-cancer drug, 5-azacytidine, applied in vitro to lymphocytes of patients prior to transplantation mimics the effect of transplantation: the epigenetic aberrations disappear while aneuploidy stays unchanged.</p> <p>Conclusions</p> <p>The reversible nature of the replication aberrations may serve as potential epigenetic blood markers for evaluating the success of transplant or other treatments and for long-term follow up of the patients who have overcome a hematological malignancy.</p

HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer

Background: HAGE protein is a known immunogenic cancer-specific antigen. Methods: The biological, prognostic and predictive values of HAGE expression was studied using immunohistochemistry in three cohorts of patients with BC (n=2147): early primary (EP-BC; n=1676); primary oestrogen receptor-negative (PER-BC; n=275) treated with adjuvant anthracycline-combination therapies (Adjuvant-ACT); and primary locally advanced disease (PLA-BC) who received neo-adjuvant anthracycline-combination therapies (Neo-adjuvant-ACT; n=196). The relationship between HAGE expression and the tumour-infiltrating lymphocytes (TILs) in matched prechemotherapy and postchemotherapy samples were investigated. Results: Eight percent of patients with EP-BC exhibited high HAGE expression (HAGEþ) and was associated with aggressive clinico-pathological features (Ps<0.01). Furthermore, HAGEþexpression was associated with poor prognosis in both univariate and multivariate analysis (Ps<0.001). Patients with HAGE+ did not benefit from hormonal therapy in high-risk ER-positive disease. HAGE+ and TILs were found to be independent predictors for pathological complete response to neoadjuvant-ACT; P<0.001. A statistically significant loss of HAGE expression following neoadjuvant-ACT was found (P=0.000001), and progression-free survival was worse in those patients who had HAGE+ residual disease (P=0.0003). Conclusions: This is the first report to show HAGE to be a potential prognostic marker and a predictor of response to ACT in patients with BC

Searching for Massive Outflows in Holmberg IX X-1 and NGC 1313 X-1: The Iron K Band

We have analysed all the good quality XMM-Newton data publicly available for the bright ULXs Holmberg IX X-1 and NGC 1313 X-1, with the aim of searching for discrete emission or absorption features in the Fe K band that could provide observational evidence for the massive outflows predicted if these sources are accreting at substantially super-Eddington rates. We do not find statistically compelling evidence for any atomic lines, and the limits that are obtained have interesting consequences. Any features in the immediate Fe K energy band (6-7 keV) must have equivalent widths weaker than ~30 eV for Holmberg IX X-1, and weaker than ~50 eV for NGC 1313 X-1 (at 99 per cent confidence). In comparison to the sub-Eddington outflows observed in GRS 1915+105, which imprint iron absorption features with equivalent widths of ~30 eV, the limits obtained here appear quite stringent, particularly when Holmberg IX X-1 and NGC 1313 X-1 must be expelling at least 5-10 times as much material if they host black holes of similar masses. The difficulty in reconciling these observational limits with the presence of strong line-of-sight outflows suggests that either these sources are not launching such outflows, or that they must be directed away from our viewing angle.Comment: 11 pages, 5 figures, accepted for publication in MNRA